Improving quality control for CAR T cell therapies
Drug Discovery World
AUGUST 10, 2022
Given the risks, it is important to detecta nd screen out RCVs in CAR T cell therapy batches. Cell-based assays often require considerable time to produce results. qPCR delivers results quickly, but manufacturers cannot necessarily use it to guarantee a CAR T cell batch’s safety due to its limited sensitivity.
246 
Let's personalize your content